Quoin Pharmaceuticals, Ltd. American Depositary Shares (QNRX) Financial Statements

Quoin Pharmaceuticals, Ltd. American Depositary Shares

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00D9PB389

XNAS · usd

7.15▼ 0.11 (-1.52%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA—

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close7.26

Day's Range7.05 – 7.65

52-Week Range3.25 – 41.80

Volume195.2K

Avg Volume1.1M

Share Statistics

Shares Outstanding

Employees6

ExchangeXNAS

Listed2021-10-28

Share count as of August 12, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Quoin Pharmaceuticals, Ltd. American Depositary Shares (QNRX)

What is Quoin Pharmaceuticals, Ltd. American Depositary Shares's Market Cap?: Quoin Pharmaceuticals, Ltd. American Depositary Shares's Market Cap is $502.6M, based on as-reported figures from SEC (XBRL) filings.
What is Quoin Pharmaceuticals, Ltd. American Depositary Shares's Enterprise Value?: Quoin Pharmaceuticals, Ltd. American Depositary Shares's Enterprise Value is $491.8M, based on as-reported figures from SEC (XBRL) filings.
What is Quoin Pharmaceuticals, Ltd. American Depositary Shares's Net Income (TTM)?: Quoin Pharmaceuticals, Ltd. American Depositary Shares's Net Income (TTM) is -$18.7M, based on as-reported figures from SEC (XBRL) filings.
What is Quoin Pharmaceuticals, Ltd. American Depositary Shares's Diluted EPS (TTM)?: Quoin Pharmaceuticals, Ltd. American Depositary Shares's Diluted EPS (TTM) is -0.27, based on as-reported figures from SEC (XBRL) filings.
What is Quoin Pharmaceuticals, Ltd. American Depositary Shares's Net Debt?: Quoin Pharmaceuticals, Ltd. American Depositary Shares's Net Debt is -$10.8M, based on as-reported figures from SEC (XBRL) filings.